Halozyme Therapeutics, Inc. (HALO)
71.67
-0.75
(-1.04%)
USD |
NASDAQ |
Jan 13, 16:00
71.62
-0.05
(-0.07%)
After-Hours: 20:00
Halozyme Therapeutics Price: 71.67 for Jan. 13, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 213.65 |
| Merck & Co., Inc. | 108.26 |
| AIM ImmunoTech, Inc. | 1.27 |
| Stryker Corp. | 355.82 |
| Skye Bioscience, Inc. | 0.98 |
Price Related Metrics
| PE Ratio | 15.06 |
| PS Ratio | 7.239 |
| PEG Ratio | 0.2623 |
| Price to Book Value | 16.73 |
| Price to Free Cash Flow | 14.93 |
| Earnings Yield | 6.64% |
| Market Cap | 8.428B |
| PEGY Ratio | 0.2623 |
| Operating PE Ratio | 12.20 |
| Normalized PE Ratio | 15.06 |